ASAP score (AFP and PIVKA-II) by CMIA*
฿1,550.00
Calculates a hepatocellular carcinoma risk score using age, sex, AFP and PIVKA-II. AFP and PIVKA-II are measured by CMIA.
Typical Use
Used as an adjunct when assessing hepatocellular carcinoma risk in people with chronic liver disease, particularly chronic hepatitis B. It does not replace imaging or clinical assessment.